If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
<br /> these include the development of new<br /> analytical methods for glycerin,<br /> melamine and heparin and the recently-<br /> announced PREDICT scheme, which<br /> will put in place a risk-based approach to<br /> screening shipments on entry into the<br /> USA.<br /> Inspection and enforcement activities<br /> have been bolstered by the opening of<br /> satellite FDA offices in other countries,<br /> notably China, India, Europe and Costa<br /> Rica, while the agency is also piloting<br /> shared inspections with other regulatory<br /> authorities, such as the European<br /> Medicines Agency (EMA) and<br /> Australia's Therapeutic Goods<br /> Administration (TGA).<br /> International collaboration and<br /> outreach is of paramount importance,<br /> according to Friedman, and the
Pharmafocus
Pharmafocus
Pharmafocus September 2010R&D NewsRoche s
Pharmafocus September 2010R&D NewsRoche s
Pharmafocus September 2010PharmafocusSeptember
Pharmafocus September 2010PharmafocusSeptember
Pharmafocus September 2010Genzyme available fo
Pharmafocus September 2010Genzyme available fo
Pharmafocus September 2010GSK's Benlysta to b
Pharmafocus September 2010GSK's Benlysta to b
Pharmafocus September 2010Sanofi's Multaq in p
Pharmafocus September 2010Sanofi's Multaq in p
Pharmafocus September 2010Alcon acquisition m
Pharmafocus September 2010Alcon acquisition m
Pharmafocus September 2010International new
Pharmafocus September 2010International new
InPharm.comIn Association with IMI
InPharm.comIn Association with IMI
Pharmafocus September 2010Generi
Pharmafocus September 2010Generi
Pharmafocus September 2010Lilly's fai
Pharmafocus September 2010Lilly's fai
Pharmafocus September 2010TalkingPointThis mo
Pharmafocus September 2010TalkingPointThis mo
Pharmafocus September 2010T he e
Pharmafocus September 2010T he e
Pharmafocus September 2010
Pharmafocus September 2010
Pharmafocus September 2010Talking Poin
Pharmafocus September 2010Talking Poin
Pharmafocus September 2010Comment
Pharmafocus September 2010Comment
Pharmafocus September 2010moulding and s
Pharmafocus September 2010moulding and s
Pharmafocus September 2010Manufacturing under
Pharmafocus September 2010Manufacturing under
is the rapidly morphing world of bio
is the rapidly morphing world of bio
Pharmafocus September 2010The FDA Intervi
Pharmafocus September 2010The FDA Intervi
these include the development of newanalytical
these include the development of newanalytical
Pharmafocus September 2010Medical, marketing &
Pharmafocus September 2010Medical, marketing &
Pharmafocus September 2010objectives to
Pharmafocus September 2010objectives to
Pharmafocus September 2010The latest on c
Pharmafocus September 2010The latest on c
Pharmafocus September 2010Working Life Dr Me
Pharmafocus September 2010Working Life Dr Me
Pharmafocus September 2010Pharmafile Review
Pharmafocus September 2010Pharmafile Review
Pharmafocus September 2010Pharma
Pharmafocus September 2010Pharma
Pharmafocus September 2010Advertising con
Pharmafocus September 2010Advertising con
Pharmafocus September 2010
Pharmafocus September 2010
Pharmafocus September 2010$SSRLQWPHQWV
Pharmafocus September 2010$SSRLQWPHQWV
Pharmafocus September 2010Sharing Know
Pharmafocus September 2010Sharing Know
Pharmafocus September 2010Plans for greater t
Pharmafocus September 2010Plans for greater t